Tidmarsh Creates More Instability And Uncertainty For US FDA, Industry

 
• By Sarah Karlin-Smith
  
picture waist down of person a bit unbalanced on a balanced board
The potential departure of relatively new CDER leader George Tidmarsh is throwing FDA and industry off balance. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership